UCL IoO study listed in top 100 articles with significant impact on clinical glaucoma care

 A 2019 study by Prof Gus Gazzard was selected in a list of top 100 Glaucoma papers in the January-February 2022 edition of the American journal Ophthalmology Glaucoma, a journal collaboration between the American Academy of Ophthalmology (AAO) and the American Glaucoma Society (AGS).

The 100 most frequently cited English-language original articles relevant to glaucoma were identified via a Scopus search. The AAO Preferred Practice Pattern Glaucoma Panel selected an additional 100 articles including newer and “classic” papers. An anonymous survey including the list of 200 articles was distributed to the AGS membership. Survey participants were asked to rate the impact of each article on the clinical care of glaucoma patients using a 4-point Likert scale. Survey respondents were able to provide “write-in” suggestions for the AGS 100. A subsequent anonymous follow-up survey was distributed asking participants to use the same Likert scale to rate 31 “write-in” articles suggested in the original survey. The AGS 100 was created by ranking the top 100 articles based on mean Likert scores from the original and follow-up surveys.

Professor Gazzard’s paper, titled “Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial” was published in the Lancet in 2019. 
 

Links 

• January-February 2022 edition of Ophthalmology Glaucoma 

• List of top 100 Glaucoma papers

• 2019 Professor Gazzard's paper published in the Lancet

• American Academy of Ophthalmology (AAO)

• American Glaucoma Society